Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.12 0.89 −2.78%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100

Smith & Nephew SNATS, Inc. (SNN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Smith & Nephew SNATS, Inc. (SNN) trades at a P/B ratio of 2.8×. Over the past ten years it has ranged from 1.8× (September 2022) to 4.5× (February 2020); the current reading is higher than 36% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.8× 32.88%
FY2024 2.1× (9.29%)
FY2023 2.3× (0.82%)
FY2022 2.3× (16.54%)
FY2021 2.8× (22.16%)
FY2020 3.6× (14.57%)
FY2019 4.2× 21.92%
FY2018 3.4× 2.05%
FY2017 3.4× (0.82%)
FY2016 3.4× (15.59%)

Quarterly newest first

Period P/B ratio Change
Jun 2023 2.7× 18.76%
Dec 2022 2.3× (0.41%)
Jun 2022 2.3× (16.96%)
Dec 2021 2.7× (23.52%)
6 more quarters

Against its own ten years

Low 1.8× High 4.5×
Ten-year median 3.4×
Current reading's percentile 40

P/B ratio against peers

Company P/B ratio
BIO Bio-Rad Laboratories, Inc. compare 1.3×
BIO.B Bio-Rad Laboratories, Inc. compare 1.3×
GMED Globus Medical, Inc. compare 2.3×
SNN Smith & Nephew SNATS, Inc. 2.8×
BRKR Bruker Corporation compare 3.7×
PODD Insulet Corporation compare 7.6×
PEN Penumbra, Inc. compare 8.0×
TXG 10x Genomics compare 9.2×
GKOS Glaukos Corporation compare 18.1×
Medical Devices industry median 2.5×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on SNN